Abstract
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare malignant tumor characterized by its epithelioid structure and vascular endothelium origin. The clinical course of HEHE is variable, ranging from long-term survival without treatment to a rapidly progressive course with a fatal outcome. As a consequence, no standard treatment has been determined. We present a case of HEHE occurring in a 13-year-old girl, in which a novel treatment approach using antiangiogenic therapy was tried and was successful in slowing the progression of the disease.
MeSH terms
-
Adolescent
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Carboplatin / administration & dosage
-
Celecoxib
-
Cisplatin / administration & dosage
-
Disease Progression
-
Doxorubicin / administration & dosage
-
Drug Therapy, Combination
-
Female
-
Hemangioendothelioma, Epithelioid / blood supply
-
Hemangioendothelioma, Epithelioid / diagnosis
-
Hemangioendothelioma, Epithelioid / drug therapy
-
Hemangioendothelioma, Epithelioid / secondary*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / therapeutic use
-
Liver Failure / etiology
-
Liver Failure / surgery
-
Liver Neoplasms / blood supply
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / pathology
-
Liver Transplantation / ethics
-
Lung Neoplasms / blood supply
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / secondary*
-
Neovascularization, Pathologic / drug therapy
-
Neovascularization, Pathologic / etiology
-
Pyrazoles / administration & dosage
-
Pyrazoles / therapeutic use
-
Radiography
-
Recombinant Proteins
-
Sulfonamides / administration & dosage
-
Sulfonamides / therapeutic use
-
Thalidomide / administration & dosage
-
Thalidomide / therapeutic use
-
Vinblastine / administration & dosage
-
Vinblastine / therapeutic use
Substances
-
Angiogenesis Inhibitors
-
Interferon alpha-2
-
Interferon-alpha
-
Pyrazoles
-
Recombinant Proteins
-
Sulfonamides
-
Thalidomide
-
Vinblastine
-
Doxorubicin
-
Carboplatin
-
Celecoxib
-
Cisplatin